Livzon Pharmaceutical Group Inc (000513) — Strategic Asset Allocation Index
Livzon Pharmaceutical Group Inc (000513) has a Strategic Asset Allocation Index of 32.3% as of September 2023. Strategic assets (PP&E of CN¥4.67 Billion plus long-term investments of CN¥-) total CN¥4.67 Billion, measured against net assets of CN¥14.47 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Livzon Pharmaceutical Group Inc (000513) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Livzon Pharmaceutical Group Inc Strategic Asset Allocation Index (2000–2021)
This chart shows how Livzon Pharmaceutical Group Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of September 2023, the index stands at 32.3%, representing strategic assets of CN¥4.67 Billion against net assets of CN¥14.47 Billion CNY. For live market cap and overall valuation, see Livzon Pharmaceutical Group Inc market cap and net worth.
Annual Strategic Asset Allocation Index for Livzon Pharmaceutical Group Inc (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Livzon Pharmaceutical Group Inc from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Livzon Pharmaceutical Group Inc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 29.6% | CN¥4.24 Billion | CN¥4.24 Billion | CN¥- | CN¥14.31 Billion | ▲ +2.4 pp |
| 2020 | 27.2% | CN¥3.71 Billion | CN¥3.71 Billion | CN¥- | CN¥13.64 Billion | ▼ -5.8 pp |
| 2019 | 33.0% | CN¥4.04 Billion | CN¥3.39 Billion | CN¥651.24 Million | CN¥12.28 Billion | ▼ -0.9 pp |
| 2018 | 33.8% | CN¥3.97 Billion | CN¥3.38 Billion | CN¥595.81 Million | CN¥11.75 Billion | ▲ +3.6 pp |
| 2017 | 30.2% | CN¥3.39 Billion | CN¥3.39 Billion | CN¥- | CN¥11.23 Billion | ▼ -23.0 pp |
| 2016 | 53.2% | CN¥3.78 Billion | CN¥3.54 Billion | CN¥238.40 Million | CN¥7.11 Billion | ▼ -28.3 pp |
| 2015 | 81.5% | CN¥3.92 Billion | CN¥3.67 Billion | CN¥248.53 Million | CN¥4.81 Billion | ▼ -4.4 pp |
| 2014 | 85.9% | CN¥3.51 Billion | CN¥3.51 Billion | CN¥- | CN¥4.08 Billion | ▼ -3.7 pp |
| 2013 | 89.6% | CN¥3.23 Billion | CN¥3.23 Billion | CN¥- | CN¥3.60 Billion | ▲ +17.2 pp |
| 2012 | 72.4% | CN¥2.30 Billion | CN¥2.30 Billion | CN¥- | CN¥3.18 Billion | ▲ +27.5 pp |
| 2011 | 44.9% | CN¥1.35 Billion | CN¥1.35 Billion | CN¥- | CN¥3.01 Billion | ▼ -2.8 pp |
| 2010 | 47.7% | CN¥1.26 Billion | CN¥1.26 Billion | CN¥- | CN¥2.64 Billion | ▲ +0.8 pp |
| 2009 | 46.9% | CN¥1.04 Billion | CN¥1.04 Billion | CN¥- | CN¥2.23 Billion | ▼ -12.0 pp |
| 2008 | 58.9% | CN¥1.08 Billion | CN¥1.08 Billion | CN¥- | CN¥1.83 Billion | ▲ +2.3 pp |
| 2007 | 56.6% | CN¥1.13 Billion | CN¥1.13 Billion | CN¥- | CN¥1.99 Billion | ▼ -22.0 pp |
| 2006 | 78.6% | CN¥1.13 Billion | CN¥1.13 Billion | CN¥- | CN¥1.44 Billion | ▼ -11.4 pp |
| 2005 | 90.0% | CN¥1.11 Billion | CN¥1.11 Billion | CN¥- | CN¥1.24 Billion | ▲ +16.5 pp |
| 2004 | 73.4% | CN¥860.59 Million | CN¥860.59 Million | CN¥- | CN¥1.17 Billion | ▲ +15.8 pp |
| 2003 | 57.7% | CN¥677.52 Million | CN¥677.52 Million | CN¥- | CN¥1.17 Billion | ▼ -1.0 pp |
| 2002 | 58.7% | CN¥663.05 Million | CN¥663.05 Million | CN¥- | CN¥1.13 Billion | ▲ +1.2 pp |
| 2001 | 57.4% | CN¥593.17 Million | CN¥593.17 Million | CN¥- | CN¥1.03 Billion | ▼ -3.3 pp |
| 2000 | 60.7% | CN¥587.22 Million | CN¥587.22 Million | CN¥- | CN¥967.05 Million | — |